Dovobet Gel Wins Japan Approval: LEO/Kyowa Kirin

February 20, 2018
The Ministry of Health, Labor and Welfare (MHLW) approved a gel formulation of LEO Pharma’s psoriasis vulgaris drug Dovobet (calcipotriol hydrate + betamethasone dipropionate) on February 16, the Denmark dermatology firm and its partner Kyowa Hakko Kirin said. Dovobet is...read more